title: Hematuria one-stop clinic: first experience in Italy with 150 cases.
abstract: OBJECTIVE
  Starting from the UK experience, we decided to test both the feasibility and the advantages of this diagnostic pathway now established in an Italian hospital. We analyzed the outcomes in detecting transitional cell carcinoma (TCC) of the bladder, other malignant and non-malignant conditions.
  
  
  METHODS
  Between April and December 2010, one hundred and fifty patients presenting with hematuria were referred to the Hematuria One Stop Clinic (HOSC) at our Institution. Each patient underwent a visit, a Urinary Tract Ultrasound, a Cystoscopy and CT IVP in selected cases (evidence of alterations or lesions of the renal parenchyma, presence of stones of the urinary tract, evidence of doubtful or positive urinary cytology). Where a TCC of the bladder was diagnosed, the patient underwent TUR-BT. In other cases (stones, BPH etc.) the appropriate therapeutic pathway was followed.
  
  
  RESULTS
  25.3% of patients with hematuria were found to have a bladder cancer; 21.3% had a urinary stone (2% in the bladder); 1.3% had prostate cancer; 1.3% had a renal cell carcinoma. The mean age was 69.8 yrs. 6% of the patients (23.6% on patients with TCC of the bladder) had a G3 disease. The mean time from admission to the HOSC until the operation day, in case of TCC of the bladder, was 10.61 days.
  
  
  CONCLUSIONS
  The Italian experience of the One Stop Clinic confirms a high rate of bladder cancer detection. Furthermore, a high rate of non-malignant conditions was detected, stressing the importance of the HOSC not only as a cancer clinic but as a complete general urological clinic. We report a shorter waiting time to operation, especially for bladder TCC G3 patients.
authors.affiliation: Academic Dep. of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. luca.carmignani@unimi.it
authors.forename: Luca
authors.initials: L
authors.lastname: Carmignani
authors.forename: Giorgio
authors.initials: G
authors.lastname: Bozzini
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Nicosia
authors.forename: Massimo
authors.initials: M
authors.lastname: Consentino
authors.forename: Stefano
authors.initials: S
authors.lastname: Picozzi
authors.forename: Stefano
authors.initials: S
authors.lastname: Casellato
authors.forename: Luca
authors.initials: L
authors.lastname: Lunelli
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery; D003558:Cystoscopy / Q000706:statistics & numerical data; D003950:Diagnostic Techniques, Urological / Q000706:statistics & numerical data*; D042241:Early Diagnosis; D005240:Feasibility Studies; D005260:Female; D006417:Hematuria / Q000209:etiology*; D006748:Hospital Departments / Q000458:organization & administration* / Q000706:statistics & numerical data; D006785:Hospitals, University / Q000458:organization & administration; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011471:Prostatic Neoplasms / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D013997:Time Factors; D014057:Tomography, X-Ray Computed / Q000706:statistics & numerical data; D052878:Urolithiasis / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D014570:Urologic Diseases / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D014571:Urologic Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery